A new perspective on liver diseases: Focusing on the mitochondria-associated endoplasmic reticulum membranes
Pharmacological Research · 2024-10 · 208 · 107409
DOI: 10.1016/j.phrs.2024.107409 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2024-10. Verfasst von Mengyu Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Beijing University of Chinese Medicine, 100029, China. Hauptthemen laut MEDLINE: Endoplasmic Reticulum, Liver Diseases. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
The pathogenesis of liver diseases is multifaceted and intricate, posing a persistent global public health challenge with limited therapeutic options. Therefore, further research into liver diseases is imperative for better comprehension and advancement in treatment strategies. Numerous studies have confirmed the endoplasmic reticulum (ER) and mitochondria as key organelles driving liver diseases. Notably, the mitochondrial-associated ER membranes (MAMs) establish a physical and functional connection between the ER and mitochondria, highlighting the importance of inter-organelle communication in maintaining their functional homeostasis. This review delves into the intricate architecture and regulative mechanism of the integrated MAM that facilitate the physiological transfer of signals and substances between organelles. Additionally, we also provide a detailed overview regarding the varied pathogenic roles of malfunctioning MAM in liver diseases, focusing on its involvement in the progression of ER stress and mitochondrial dysfunction, the regulation of mitochondrial dynamics and Ca2+ transfer, as well as the disruption of lipid and glucose homeostasis. Furthermore, the current challenges and prospects associated with MAM in liver disease research are thoroughly discussed. In conclusion, elucidating the specific structure and function of MAM in different liver diseases may pave the way for novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Sciences, Beijing University of Chinese Medicine, 100029, China.
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, 100029, China.
- School of Life Sciences, Beijing University of Chinese Medicine, 100029, China. Electronic address: xiaojiaoyang.li@bucm.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Guo, M., Liu, R., Zhang, F., Qu, J., Yang, Y., & Li, X. (2024). A new perspective on liver diseases: Focusing on the mitochondria-associated endoplasmic reticulum membranes. Pharmacological Research, 208, 107409. https://doi.org/10.1016/j.phrs.2024.107409
Vancouver
Guo M, Liu R, Zhang F, Qu J, Yang Y, Li X. A new perspective on liver diseases: Focusing on the mitochondria-associated endoplasmic reticulum membranes. Pharmacological Research. 2024;208:107409. doi:10.1016/j.phrs.2024.107409
BibTeX
@article{Guo2024,
author = {Guo, Mengyu and Liu, Runping and Zhang, Fukun and Qu, Jiaorong and Yang, Yun and Li, Xiaojiaoyang},
title = {A new perspective on liver diseases: Focusing on the mitochondria-associated endoplasmic reticulum membranes},
journal = {Pharmacological Research},
year = {2024},
volume = {208},
pages = {107409},
doi = {10.1016/j.phrs.2024.107409}
}
EUVIMED